Share This Blog
- Luncheon with the Experts in New York City -- Carcinoid and Neuroendocrine Tumor Patients Are Invited!
- Carcinoid and Neuroendocrine Tumor Specialist Dr. Eugene A. Woltering Named Chair of AJCC Expert Panel
- A Possible Cure for Neuroendocrine Cancer: Exciting Update!
- But You Look So Good . . . Stories by Carcinoid Cancer Survivors
- FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)
- @a_swisstory sent you an email to connect with others in the #carcinoid #NETCancer community. Hope you got it! 4 days ago
- Do #doctors need guidance treating #NeuroendocrineCancer patients? Great online resource for physicians: bit.ly/1sNdaPg 5 days ago
- Recognizing great #cancer advocates on #FF: @teaminspire, @jangeissler, @myHEARTyrHANDS, @PLANETSCHARITY, @RareDiseases, @DominicNutt. 5 days ago
- @CarcinoidStory, we've learned more about how you connect with/create a group in Switzerland. Can you contact us via our website? 1 week ago
- Dr. Eugene Woltering named Chair of @AJCCancer Expert Panel on #NeuroendocrineTumors. bit.ly/1hXy0Xv http://t.co/aYBuQ52P27 1 week ago
Daily Archives: December 17, 2009
“Serotonin seems to be the single most damaging substance in carcinoid heart disease,” explains JEROME S. ZACKS, MD. Dr. Zacks, a cardiologist, is a member of the Carcinoid/ Neuroendocrine Tumor Center at Mount Sinai School of Medicine in New York … Continue reading